Metraipolis › archive › dc_8f4aef257337

Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAFV600E/K-mutant metastatic melanoma — Europe PMC PMID:41843134

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41843134
DOI
10.1007/s00280-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-04T08:30:40.875Z
SHA-256 of the archived text
f583cc49fff4903a67b4403c584bb539efd53ecdc6f3c934b36bd5e41d9caf34
Stable URL of this page
https://metraipolis.com/documento/dc_8f4aef257337

How to cite

Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAFV600E/K-mutant metastatic melanoma — Europe PMC PMID:41843134 — Europe PMC (en), https://europepmc.org/article/MED/41843134 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8f4aef257337 (Metraipolis archive dc_8f4aef257337, sha256 f583cc49fff4903a67b4403c584bb539efd53ecdc6f3c934b36bd5e41d9caf34)
BibTeX
@misc{dc8f4aef257337,
  title = {Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAFV600E/K-mutant metastatic melanoma — Europe PMC PMID:41843134},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41843134},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8f4aef257337; sha256 f583cc49fff4903a67b4403c584bb539efd53ecdc6f3c934b36bd5e41d9caf34},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41843134. Agents can read the archived copy with the MCP tool read_document.